Biopharmaceutical Development and CGMP Manufacturing: Expansion of Capacities for Clinical and Commercial Supply

Thilo Kamphausen

August 27, 2021

1 Min Read

19-7-8-RichterHelm_1-300x182.jpgRichter-Helm BioLogics is a leading and steadily growing contract manufacturer based in Germany. We comply with good manufacturing practice (GMP) and specialize in microbial biopharmaceutical products. Our work focuses on recombinant proteins, plasmid DNA, antibody fragments, and vaccines. BPI_A_141207AR41_O_F0002g.jpgClients worldwide already have benefited from our commitment to GMP, flexibility, and total transparency. With a proven 30-year track record and highly skilled professionals, Richter-Helm supports you with process development, supply of products for clinical trials, commercial production, in-house quality control (QC) testing, and qualified-person (QP) release. We operate two GMP-compliant production plants with bioreactor capacities of up to 1,500 L. Two additional bioreactors with capacities of 300 L and 1,500 L for microbial production will be added. That includes establishment of mid- and downstream processing and supporting utilities. By end of 2023, the new trains will be fully operational.

Fill out the form below to read the complete capabilities review and learn more about microbial biopharmaceutical products now.

You May Also Like